(Reuters) – GlaxoSmithKline executives in China have confessed to bribery and tax violations, the country’s security ministry said on Thursday, during one of a string of investigations into foreign firms in the world’s second-biggest economy.
The ministry said the case against Britain’s biggest drugmaker involved a large number of staff and a huge sum of money over an extended period of time, with bribes offered to Chinese government officials, medical associations, hospitals and doctors to boost sales and prices.
Read Full Article HERE
Michael Martina and Adam Jourdan, Reuters via CHINA US Focus http://feedproxy.google.com/~r/ChinaUsFocus/~3/NDvBoY3ve8M/
No comments:
Post a Comment